291 results
Page 2 of 15
8-K
EX-99.1
77ek18mfjg60 onw
31 Oct 23
Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344
8:00am
8-K
EX-99.1
2eg geyem
16 Aug 23
Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
4:05pm
424B5
ob2tjozk1xi2cal7le6p
15 Jun 23
Prospectus supplement for primary offering
4:54pm
UPLOAD
fclpr13imt7r0
19 May 23
Letter from SEC
12:00am
8-K
EX-99.1
c37k8h 31c4q9n
15 May 23
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:00am